Abstract
Objective
To create a predictive model for the treatment approach to community-acquired pneumonia (CAP) in patients needing Intensive Care Unit (ICU) admission.
Design
Multicenter prospective study
Setting
Twenty-six Spanish ICUs.
Patients
One hundred seven patients with CAP, all of them with accurate etiological diagnosis, divided in three groups according to their etiology in typical (bacterial pneumonia),Legionella and other atypical (Mycoplasma, Chlamydia spp. and virus). For the multivariate analysis we groupedLegionella and other atypical etiologies in the same category.
Methods
We recorded 34 variables including clinical characteristics, risk factors and radiographic pattern. We used a multivariate logistic regression analysis to find out a predictive model.
Results
We have the complete data in 70 patients. Four variables: APACHE II, (categorized as a dummy variable) serum sodium and phosphorus and “length of symptoms” gave an accurate predictive model (c=0.856). From the model we created a score that predicts typical pneumonia with a sensitivity of 90.2% and specificity 72.4%.
Conclusion
Our model is an attempt to help in the treatment approach to CAP in ICU patients based on a predictive model of basic clinical and laboratory information. Further studies, including larger numbers of patients, should validate and investigate the utility of this model in different clinical settings.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Sorensen J, Cederholm I, Carlsson C (1986) Pneumonia: a deadly disease despite intensive care treatment. Scand J Infect Dis 18: 329–335
Torres A, Serra-Batlles J, Ferrer A, Jimenez P, Celis R, Cobo E, Rodriguez Roisin R (1991) Severe community-acquired pneumonia. Epidemiology and prognostic factors. Am Rev Respir Dis 144: 312–318
Örtqvist A, Sterner G, Nilsson JA (1985) Severe community-acquired pneumonia. Factors influencing need of intensive care treatment and prognosis. Scand J Infect Dis 17: 377–386
Alkahayer M, Jenkins PF, Harrison BDW (1990) The outcome of community-acquired pneumonia treated on the intensive care unit. Respir Med 84: 13–16
British Thoracic Society (1993) Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. Br J Hosp Med 49: 346–350
Rello J, Quintana E, Ausina V, Net A, Prats G (1993) A three-year study of severe community-acquired pneumonia with emphasis on outcome. Chest 103: 232–235
Moine P, Verken JB, Chevret S, Chastang C, Gajdos P, and the French Study Group for community-acquired pneumonia in Intensive Care Units (1994) Severe community-acquired pneumonia. Etiology, epidemiology, and prognosis factors. Chest 105: 1487–1495
Sorensen J, Forsberg P Hakason E, Maller R, Sederholm C, Söreén L, Carlsson C (1989) A new diagnostic approach to the patient with severe pneumonia. Scand J Infect Dis 21: 33–41
MacDonald KS, Scriver SR, Skulnick M, Low DE (1994) Community-acquired pneumonia: the future of the microbiology laboratory: focused diagnosis or syndromic management? Semin Respir Infect 9: 180–188
Fein AM, Niederman MS (1995) Guidelines for the initial management of community-acquired pneumonia: savory recipe or cookbook for disaster? Am J Respir Crit Care Med 152: 1149–1153
Cunha BA (1995) The antibiotic treatment of community-acquired, atypical and nosocomial pneumonias. Med. Clin North Am 79: 581–597
Mundy LM, Auwaerter PG, Oldach D, Warner ML, Burton A, Vance E, Gaydos CA, Joseph JM, Gopalan R, Moore RD, Quinn TC, Charache P, Bartlett J (1995) Community-acquired pneumonia: impact of immune status. Am J Respir Crit Care Med 152: 1309–1315
Bartlett JG, Mundy LM (1995) Community-acquired pneumonia. N Engl J Med 333: 1618–1624
Pareja A, Bernal C, Leyva A, Piedrola G, Maroto C (1992) Etiology study of patients with community-acquired pneumonia. Chest 101: 1207–1210
Campbell GD (1994) Overview of community-acquired pneumonia Prognosis and clinical features. Med Clin North Am 78: 1035–1048
Fang GD, Fine M, Orloff J Arisumi D, Yu VL, Kapoor W, Grayston JT, Wang SP, Kohler R, Muder RR, Yee YC, Rihs JD, Vickers RM (1990) New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 350 cases. Medicine 69: 307–316
Granados A, Podzamezer D, Gudiol F, Manresa F (1989) Pneumonia due to Legionella pneumophilla and pneumococcal pneumonia: similarities and differences on presentation. Eur Respir J 2: 130–134
Marrie TJ (1994) Community-acquired pneumonia. Clin Infect Dis 18: 501–515
Niederman MS, Bass JB Jr, Campbell GD, Fein AM, Grossman RF, Mandell LA, Marrie TJ, Sarosi GA, Torres A, Yu VL (1993) Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 148: 1418–1426
Macfarlane JT, Miller AC, Roderick Smith WH, Morris AH, Rose DH (1984) Comparative radiographic features of community acquired Legionnaires' disease, pneumococcal pneumonia, mycoplasma pneumonia, and psittacosis. Thorax 39: 28–33
Woodhead MA, Macfarlane JT (1987) Comparative clinical and laboratory features of legionella with pneumococcal and mycoplasma pneumonias. Br J Dis Chest 81: 133–139
Knaus WA, Draper E, Wagner DP, Zimmerman JE (1985) Apache II. A severity of disease classification system. Crit Care Med 13: 818–829
Feldman C, Kallenbach JM, Levy H, Reinach SG, Hurwitz MD, Thoburn JR, Koornhof HJ (1989) Community-acquired pneumonia of diverse aetiology: prognostic features in patients admitted to an intensive care unit and a “severity of illness” score. Intensive Care Med 15: 302–307
Farr BM, Sloman AJ, Fisch MJ (1991) Predicting death in patients hospitalized for community-acquired pneumonia. Ann Intern Med 115: 428–436
McCabe WR, Jackson GG (1962) Gram-negative bacteremia, clinical, laboratory and therapeutic observations. Arch Intern Med 110: 83–91
Pachón J, Prados MD, Capote F, Cuello JA, Garnacho J, Verano A (1990) Severe community-acquired pneumonia. Etiology, prognosis, and treatment. Am Rev Respir Dis 142: 369–373
Miller AC (1979) Early clinical differentiation between Legionnaires' disease and other sporadic pneumonias. Ann Intern Med 90: 525–528
Helms CM, Viner JP, Sturm RH, Renner ED, Johnson W (1979) Comparative features of pneumococcal, mycoplasma and legionnaires' disease pneumonias. Ann Intern Med 90: 543–547
Miller AC (1982) Hyponatremia in Legionnaires' disease. Br. Med J 284: 558–559
Yu VL, Kroboth FJ, Shonnard J, Brown A, Mc Dearman S, Magnusen M (1982) Legionnaires' disease: new clinical perspective from a prospective pneumonia study. Am J Med 73: 357–361
Reiman HA (1938), An acute infection of the respiratory tract with atypical pneumonia. JAMA 111: 2377–2384
Mandell LA (1995) Community-acquired pneumonia. Etiology, epidemiology, and treament. Chest 108: 35S-42S
Lehtomaki K (1988) Clinical diagnosis of pneumococal, adenoviral, mycoplasma and mixed pneumonias in young men. Eur Respir J 4: 324–329
Farr BM, Kaiser DL, Harrison BD, Connolly CK (1989) Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee. thorax 44: 1031–1035
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Olaechea, P.M., Quintana, J.M., Gallardo, M.S. et al. A predictive model for the treatment approach to community-acquired pneumonia in patients needing ICU admission. Intensive Care Med 22, 1294–1300 (1996). https://doi.org/10.1007/BF01709541
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01709541